Global biotechnology company Biogen opens a Technical Scientific Office in Saudi Arabia
Riyadh, Kingdom Saudi Arabia, gulftech – Biogen Inc. (Nasdaq: BIIB), one of the world’s first global biotechnology companies and pioneers in neuroscience, has announced the opening of its Technical Scientific Office in Saudi Arabia as part of plans to bring further scientific/medical support to serve patients and local stakeholders including healthcare practitioners, organizations and the Saudi Food and Drug Authority.
Further contributing to the standard of patient care, Biogen was a sponsor of the Saudi Pediatric Neurology Society 6th Annual Pediatric Neurology Conference, that was held in Jeddah from November 18 to 20,2021. Biogen shared the latest guidelines and best practices in pediatric neurology at special symposia at the conference. The team also actively participated in these sessions alongside leading pediatric neurologists from the Kingdom, to discuss important topics including ways to accelerate identification and management of the different types of SMA among patients.
Founded in 1978, Biogen has led pioneering scientific research for over four decades with the goal of addressing devastating neurological diseases. The Technical Scientific Office will provide the company with a base whilst working closely with the Saudi Food and Drug Authority.
Mihai Briciu, General Manager Saudi Arabia, said “Saudi Arabia has a strong healthcare infrastructure, and we are honored to be a partner of the Kingdom in further strengthening the standards of patient care. We will work towards meeting the needs of the community by bringing best practices in spinal muscular atrophy (SMA) and pediatric neurology through our new scientific office. This is part of our commitment to enhance the standards of healthcare and promote the well-being of the community. We aim to bring our innovative portfolio, in key therapeutic areas to enhance the quality of patient care.”
Fraser Hall, President of the Intercontinental Region, Biogen expressed: “At Biogen, we are expanding our geographical footprint around the world, specifically in the Middle East, in order to help more patients and to offer cutting edge solutions to those living with devastating neurological conditions. This allows us to better understand the local needs of patients and their families and share the common effort for the high-quality care of a vulnerable patient community. We are very honored and proud to support the people of this region.”
In recent years, the healthcare system in Saudi has witnessed a significant transformation as part of the Saudi Vision 2030, to offer a comprehensive, effective, and integrated health system based on the health of its population. Biogen aims to support the Kingdom’s ambitions for the future, as a trusted partner, in advanced healthcare delivery, especially to meet specialized pediatric neurology services.
For decades, Biogen has worked with health authorities, regulatory bodies, health care professionals and patient organizations to benefit people living with serious neurological and neurodegenerative diseases.
